1. Co-expression Network Analysis Reveals Novel Genes Underlying Alzheimer’s Disease Pathogenesis
   Rui-ting Hu et al, 2020, Front. Aging Neurosci. CrossRef
2. Aconiti lateralis Radix Praeparata inhibits Alzheimer’s disease by regulating the complex regulation network with the core of GRIN1 and MAPK1
   Yutao Wang et al, 2021, Pharmaceutical Biology CrossRef
3. Post‐transcriptional regulation of α7 nAChR expression by miR‐98‐5p modulates cognition and neuroinflammation in an animal model of Alzheimer's disease
   Chenghuan Song et al, 2021, FASEB j. CrossRef
4. Multifunctional Metal–Organic Framework as a Versatile Nanoplatform for Aβ Oligomer Imaging and Chemo-Photothermal Treatment in Living Cells
   Xueyan Yan et al, 2021, Anal. Chem. CrossRef
5. sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model
   Rui Zhang et al, 2021, Molecular Therapy CrossRef
6. Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1–42 through Nrf2/HO-1 and NF-κB signaling pathway in mice
   ShiYu Jin et al, 2021, International Immunopharmacology CrossRef
7. Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
   Qin Ouyang et al, 2022, Small CrossRef
8. Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice
   Yanhong Duan et al, 2022, Neuropharmacology CrossRef
9. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
   Divya Yadav et al, 2022, Neurochemistry International CrossRef
10. Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease
    Kazuyuki Takata et al, 2022, Molecules CrossRef
11. Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
    Boris Decourt et al, 2022, JEP CrossRef
12. Alpha7 nicotinic acetylcholine receptor agonist PHA-543613 improves memory deficits in presenilin 1 and presenilin 2 conditional double knockout mice
    Junyan Lv et al, 2023, Experimental Neurology CrossRef
13. Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs
    Elif Alan et al, 2023, Fundamemntal Clinical Pharma CrossRef
14. Unbalanced Regulation of α7 nAChRs by Ly6h and NACHO Contributes to Neurotoxicity in Alzheimer's Disease
    Meilin Wu et al, 2021, J. Neurosci. CrossRef
15. Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
    Weimin Qiu et al, 2023, Medicinal Research Reviews CrossRef
16. Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins
    Han-Shen Tae et al, 2023, Pharmacological Research CrossRef
17. Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders
    Matthew Fecik et al, 2023 CrossRef
18. Recent advances in nanotechnology for combating Alzheimer's disease
    Chuan Hu et al, 2023, Mater. Chem. Front. CrossRef
19. Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech
    Aditi Pradhan et al, 2024, Cell. Mol. Life Sci. CrossRef
20. A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor
    Sanskar Ranglani et al, 2024, Mol Neurobiol CrossRef
21. Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota
    Lu Han et al, 2024, Brain Research CrossRef
22. Self-assembled low molecular weight chitosan-bilobalide microsuspension protects hippocampal toxicity in amyloid beta(25-35) induced mice
    P. Pramod Kumar et al, 2024, Carbohydrate Polymer Technologies and Applications CrossRef
23. MiR-137-3p mechanisms of action and blood-brain barrier penetrating and neuron-targeting lipid nanoparticles deliver miR-137-3p for the treatment of Alzheimer's disease
    Shiyue Zhou et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
24. Alterations in Neuronal Nicotinic Acetylcholine Receptors in the Pathogenesis of Various Cognitive Impairments
    Zhi‐Zhong Guan, 2024, CNS Neurosci Ther CrossRef
25. Neuroprotective Effects of Thymol and p-Cymene in Immobilized Male rats through Alterations in Molecular, Biochemical, Histological, and Behavioral Parameters
    Masoumeh Asle-Rousta et al, 2025, Neurochem Res CrossRef